According to Covaris, the DNA shearing service is a nice alternative sample prep tool for next-generation sequencing customers. In addition, Covaris is introducing eCommerce capability on its website. This will enable customers to order commonly used consumables directly online.
The Covaris process is validated and compatible with all next-gen sequencing platforms. This process is highly reproducible and gives narrow size distribution. The isothermal, non-contact processing, in closed vessels, results in high recovery and no cross contamination, which are critical for any sequencing applications downstream, said Covaris.
The Covaris technology foundation is its proprietary and patented AFA (Adaptive Focused Acoustics) technology. The AFA technology enables numerous non-contact, isothermal processes to be developed, for use in a broad range of applications in genomics, proteomics and drug discovery research, which could not be obtained prior to the development of AFA technology, the company said.
Jim Laugharn, president and CEO of Covaris, said: “With the launch of our DNA shearing service, researchers can immediately take advantage of our technology without having to purchase the instrument first.
“The service is ideal for several groups of customers – those who only need to process small amount of samples periodically; those who are waiting for capital budget approval for instrument purchase, and those who just want to evaluate the technology without long-term commitment. For these investigators, the DNA shearing service is a cost-effective way to ‘test drive’ the Covaris AFA technology.”